Join the Atorvastatin group to help and get support from people like you.
Atorvastatin News
Tens Of Thousands of Heart Attacks, Strokes Could Be Prevented With Cholesterol Lowering Medications
WEDNESDAY, July 2, 2025 — Tens of thousands of people suffer needless heart attacks and strokes every year because they aren’t taking cholesterol-lowering drugs, a new study says. More than 39,000 dea...
Statin Use Linked to Reduced Mortality for Patients With Sepsis
THURSDAY, June 12, 2025 – For critically ill adults with sepsis, statin use is associated with reduced mortality, according to a study published online June 5 in Frontiers in Immunology. Caifeng Li,...
Statins Appear Effective In Treating Sepsis
TUESDAY, June 10, 2025 — Statins are a gold-standard treatment for lowering cholesterol, but a new study shows the inexpensive drugs could provide another life-saving service. Patients with sepsis a...
Common Medications Tied to Older Age at Onset of Parkinson Disease
FRIDAY, April 25, 2025 – Multiple common medications are associated with a considerable delay of Parkinson disease (PD) symptom onset, according to a study published online March 6 in the Journal of...
Two-Drug Combo of a Statin Plus Ezetimibe, Lowers Cholesterol Better Than Statins Alone
TUESDAY, March 25, 2025 – Statins are very cheap and highly effective cholesterol-lowering drugs – but high-risk heart patients may have an even better option, a new evidence review says. Combining...
Small but Important Differences Seen Between Rosuvastatin, Atorvastatin
WEDNESDAY, Oct. 30, 2024 – There are small but important differences in risk for some clinical outcomes associated with rosuvastatin and atorvastatin, according to a study published online Oct. 29...
FDA Medwatch Alert: FDA Requests Removal of Strongest Warning Against Using Cholesterol-Lowering Statins During Pregnancy; Still Advises Most Pregnant Patients Should Stop Taking Statins
What safety information is FDA announcing? The U.S. Food and Drug Administration (FDA) is requesting removal of its strongest warning against using cholesterol-lowering statin medicines in pregnant...
FDA Medwatch Alert: Red Yeast Rice by Doctor’s Best: Recall - Undeclared Lovastatin
ISSUE: Doctor’s Best is voluntarily recalling lot 3121005 (7379 bottles) of Red Yeast Rice dietary supplement, 600 mg Capsules, 120-count bottles to the retail level. Doctor’s Best Red Yeast Rice has ...
FDA Approves Merck’s Liptruzet (ezetimibe and atorvastatin), a New Product That Can Help Lower LDL Cholesterol
Friday, May 3, 2013 - Merck, known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration (FDA) has approved Liptruzet (ezetimibe and atorvastatin)...
FDA Medwatch Alert: Atorvastatin Calcium Tablets by Ranbaxy Inc.: Recall - Presence of Foreign Substance
ISSUE: On November 9, 2012, Ranbaxy Inc. initiated a voluntary recall of 41 affected lots of Atorvastatin Calcium Tablets (10 mg, 20 mg and 40 mg) which is a solid oral dosage form, to the retail l...
FDA Medwatch Alert: Statins and HIV or Hepatitis C Drugs: Drug Safety Communication - Interaction Increases Risk of Muscle Injury
ISSUE: FDA notified healthcare professionals of updates to the prescribing information concerning interactions between protease inhibitors and certain statin drugs. Protease inhibitors and statins ...
FDA Medwatch Alert: Statin Drugs - Drug Safety Communication: Class Labeling Change
ISSUE: FDA has approved important safety label changes for the class of cholesterol-lowering drugs known as statins. The changes include removal of routine monitoring of liver enzymes from drug...
Further information
Related condition support groups
High Cholesterol, High Cholesterol - Familial Homozygous, High Cholesterol - Familial Heterozygous, Prevention of Cardiovascular Disease